Please wait a minute...
文章检索
预防医学  2025, Vol. 37 Issue (10): 1029-1034    DOI: 10.19485/j.cnki.issn2096-5087.2025.10.011
  肿瘤流行病学专题 本期目录 | 过刊浏览 | 高级检索 |
2012—2021年吴江区肺癌发病趋势及年龄变化分析
张荣艳1, 顾思义1, 杨梅1, 沈建新1, 崔俊鹏2, 陆艳2
1.苏州市吴江区疾病预防控制中心,江苏 苏州 215200;
2.苏州市疾病预防控制中心,江苏 苏州 215000
Trend in incidence and change in age at onset of lung cancer in Wujiang District from 2012 to 2021
ZHANG Rongyan1, GU Siyi1, YANG Mei1, SHEN Jianxin1, CUI Junpeng2, LU Yan2
1. Wujiang District Center for Disease Control and Prevention, Suzhou, Jiangsu 215200, China;
2. Suzhou Center for Disease Control and Prevention, Suzhou, Jiangsu 215000, China
全文: PDF(1040 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解2012—2021年江苏省苏州市吴江区肺癌发病趋势及年龄变化,为加强肺癌防控提供依据。方法 通过吴江区肿瘤随访登记信息系统收集2012—2021年肺癌发病资料,计算粗发病率、35~64岁截缩发病率和0~74岁累积发病率;采用2000年第五次全国人口普查标准人口年龄构成计算中国人口标化发病率(中标发病率)、中标平均发病年龄和中标发病构成比。计算平均年度变化百分比(AAPC)分析2012—2021年肺癌发病变化趋势;采用线性回归模型分析2012—2021年肺癌中标平均发病年龄变化趋势。结果 2012—2021年吴江区肺癌粗发病率为84.57/10万,中标发病率为37.28/10万,35~64岁截缩发病率为52.10/10万,呈上升趋势(AAPC=2.489%、2.034%和4.654%,均P<0.05);0~74岁累积发病率为4.48%,趋势无统计学意义(P>0.05)。男性肺癌中标发病率为48.16/10万,高于女性的26.81/10万;女性肺癌中标发病率呈上升趋势(AAPC=8.174%,P<0.05),男性趋势无统计学意义(P>0.05)。全人群和女性0~<45岁(AAPC=18.287%和25.343%,均P<0.05)、45~<55岁(AAPC=8.003%和17.629%,均P<0.05)组肺癌粗发病率呈上升趋势。全人群和女性肺癌中标平均发病年龄分别由2012年的67.58和65.48岁下降至2021年的60.15和54.88岁,分别年均降低0.611和0.964岁(均P<0.05)。全人群和女性<65岁肺癌中标发病构成比呈上升趋势(AAPC=3.879%和4.639%,均P<0.05)。男性肺癌中标平均发病年龄和中标发病构成比趋势无统计学意义(均P>0.05)。结论 2012—2021年吴江区肺癌发病率呈上升趋势,发病年龄年轻化,中青年女性是肺癌防控的重点人群。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
张荣艳
顾思义
杨梅
沈建新
崔俊鹏
陆艳
关键词 肺癌发病率发病年龄平均年度变化百分比    
AbstractObjective To investigate the trend in incidence and change in age at onset of lung cancer in in Wujiang District, Suzhou City, Jiangsu Province from 2012 to 2021, so as to provide a basis for strengthening targeted prevention and control of lung cancer. Methods Data of lung cancer incidence from 2012 to 2021 were collected through the Wujiang District Tumor Follow-up Registration Information System. The crude incidence, truncated incidence for 35 to 64 years, and cumulative incidence for 0 to 74 years were calculated. Chinese population-standardized incidence, Chinese population-standardized average age at onset, and Chinese population-standardized incidence proportion were calculated using the age structure of the standard population from the Fifth National Population Census in 2000. The trend in incidence of lung cancer from 2012 to 2021 was evaluated using average annual percent change (AAPC). The trend in the Chinese population-standardized average age at onset of lung cancer from 2012 to 2021 was evaluated using a linear regression model. Results From 2012 to 2021, the crude incidence, the Chinese population-standardized incidence and truncated incidence for 35 to 64 years of lung cancer in Wujiang District were 84.57/105, 37.28/105 and 52.10/105, respectively, all showing upward trends (AAPC=2.489%, 2.034% and 4.654%, all P<0.05). The cumulative incidence for 0 to 74 years was 4.48%, showing no significant trend (P>0.05). The Chinese population-standardized incidence was higher in males than in females (48.16/105 vs. 26.81/105). The Chinese population-standardized incidence of lung cancer in females showed an upward trend (AAPC=8.174%, P<0.05), while the trend in males was not statistically significant (P>0.05). The crude incidence of lung cancer showed upward trends in the total population and females aged 0-<45 years (AAPC=18.287% and 25.343%, both P<0.05) and those aged 45-<55 age group (AAPC=8.003% and 17.629%, both P<0.05). The Chinese population-standardized average age at onset of lung cancer in total population and females decreased from 67.58 and 65.48 years in 2012 to 60.15 and 54.88 years in 2021, with an average annual reduction of 0.611 and 0.964 years, respectively (both P<0.05). The Chinese population-standardized incidence proportion showed upward trends for the total population and females under 65 years (AAPC=3.879% and 4.639%, both P<0.05). No statistically significant trends were observed in the Chinese population-standardized average age at onset or incidence proportion in males (both P>0.05). Conclusions From 2012 to 2021, the incidence of lung cancer in Wujiang District showed an increasing trend and a trend toward younger onset age. Young and middle-aged females had emerged as a key target population for lung cancer prevention and control.
Key wordslung cancer    incidence    age at onset    average annual percent change
收稿日期: 2025-09-04      修回日期: 2025-09-19     
中图分类号:  R734.2  
基金资助:江苏省老年健康科研项目(LKM2023038); 苏州市科技发展计划医疗卫生科技创新项目(SKYD2023161); 苏州市吴江区“科教兴卫”项目(WWK202329)
作者简介: 张荣艳,硕士,副主任医师,主要从事慢性病防治研究工作
通信作者: 顾思义,E-mail:691254790 @qq.com   
引用本文:   
张荣艳, 顾思义, 杨梅, 沈建新, 崔俊鹏, 陆艳. 2012—2021年吴江区肺癌发病趋势及年龄变化分析[J]. 预防医学, 2025, 37(10): 1029-1034.
ZHANG Rongyan, GU Siyi, YANG Mei, SHEN Jianxin, CUI Junpeng, LU Yan. Trend in incidence and change in age at onset of lung cancer in Wujiang District from 2012 to 2021. Preventive Medicine, 2025, 37(10): 1029-1034.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.10.011      或      http://www.zjyfyxzz.com/CN/Y2025/V37/I10/1029
[1] 韩仁强,缪伟刚,俞浩,等.2020年江苏省恶性肿瘤发病和死亡现状分析[J].江苏预防医学,2024,35(5):568-574.
HAN R Q,MIAO W G,YU H,et al.Incidence and mortality analysis of cancers in Jiangsu Province in 2020[J].Jiangsu J Prev Med,2024,35(5):568-574.(in Chinese)
[2] 鲁斌元,丁冠江,胡守财,等.1990—2021年中国呼吸道恶性肿瘤的疾病负担及变化趋势分析[J/OL].中国胸心血管外科临床杂志,2025[2025-09-19].https://link.cnki.net/urlid/51.1492.r.20250409.1359.024.
LU B Y,DING G J,HU S C,et al.Disease burden and changing trend of respiratory tract malignancies from1990 to 2021 in China[J/OL].Chin J Clin Thorac Cardiovasc Surg,2025[2025-09-19].https://link.cnki.net/urlid/51.1492.r.20250409.1359.024.(in Chinese)
[3] 郑荣寿,陈万青.癌症发病年龄变化分析[J].中华预防医学杂志,2018,52(6):673-674.
ZHENG R S,CHEN W Q.An introduction to the analysis of the age changes for cancer incidence[J].Chin J Prev Med,2018,52(6):673-674.(in Chinese)
[4] 赫捷,魏文强.2022中国肿瘤登记年报[M].北京:人民卫生出版社,2025.
HE J,WEI W Q.China cancer registry annual report 2022[M].Beijing:People's Medical Publishing House,2025.(in Chinese)
[5] 朱宝立,周金意,韩仁强.江苏省恶性肿瘤报告(2022)[M].南京:东南大学出版社,2024.
ZHU B L,ZHOU J Y,HAN R Q.Jiangsu cancer report(2022)[M].Nanjing:Southeast University Press,2024.(in Chinese)
[6] 江雨琛,俞浩,罗鹏飞,等.1990—2019年江苏省肺癌疾病负担及其危险因素变化趋势研究[J].中国肿瘤,2022,31(5):327-334.
JIANG Y C,YU H,LUO P F,et al.Trends of burden on lung cancer and related risk factors in Jiangsu Province from 1990 to 2019[J].China Cancer,2022,31(5):327-334.(in Chinese)
[7] 李金,黄文,陈奇峰.2014—2019年绍兴市肺癌发病趋势分析[J].预防医学,2021,33(9):889-892.
LI J,HUANG W,CHEN Q F.Trend of lung cancer incidence in Shaoxing City from 2014 to 2019[J].China Prev Med J,2021,33(9):889-892.(in Chinese)
[8] 项彩英,汪德兵.2011—2022年开化县肺癌发病和死亡趋势分析[J].预防医学,2023,35(10):885-889.
XIANG C Y,WANG D B.Trends in incidence and mortality of lung cancer in Kaihua County from 2011 to 2022[J].China Prev Med J,2023,35(10):885-889.(in Chinese)
[9] HILL W,LIM E L,WEEDEN C E,et al.Lung adenocarcinoma promotion by air pollutants[J].Nature,2023,616(7955):159-167.
[10] 夏昌发,陈万青.中国恶性肿瘤负担归因于人口老龄化的比例及趋势分析[J].中华肿瘤杂志,2022,44(1):79-85.
XIA C F,CHEN W Q.Fractions and trends of cancer burden attributable to population ageing in China[J].Chin J Oncol,2022,44(1):79-85.(in Chinese)
[11] 白勇,李萍,姜楠.肥胖、外周血血脂指标与非小细胞肺癌的孟德尔随机化研究[J].预防医学,2024,36(6):518-522.
BAI Y,LI P,JIANG N.Associations of obesity and peripheral blood lipid indicators with non-small cell lung cancer:a Mendelian randomization study[J].China Prev Med J,2024,36(6):518-522.(in Chinese)
[12] 谢栋臣,张莉,何纳,等.上海浦东新区九种筛检癌症发病率与死亡率变化模式及过度诊断分析[J].中华肿瘤防治杂志,2025,32(10):599-607.
XIE D C,ZHANG L,HE N,et al.Changing patterns and potential overdiagnosis of major screened cancers in Pudong New Area of Shanghai[J].Chin J Cancer Prev Treat,2025,32(10):599-607.(in Chinese)
[13] 徐仙会,陈杨,朱云芳,等.2020年云南省肿瘤登记地区肺癌发病和死亡情况及2012—2020年趋势分析[J].实用肿瘤学杂志,2024,38(6):367-371.
XU X H,CHEN Y,ZHU Y F,et al.Incidence and mortality of lung cancer in cancer registration areas of Yunnan Province in 2020 and the trends from 2012 to 2020[J].Pract Oncol J,2024,38(6):367-371.(in Chinese)
[14] 丁贤彬,吕晓燕,焦艳,等.2019年重庆市30岁及以上人群归因于被动吸烟的肺癌疾病负担研究[J].实用预防医学,2022,29(8):911-915.
DING X B,LYU X Y,JIAO Y,et al.Disease burden of lung cancer attributable to passive smoking among population aged 30 years and above in Chongqing Municipality,2019[J].Pract Prev Med,2022,29(8):911-915.(in Chinese)
[15] 孙鑫,覃文进,刘理礼,等.肺癌发病危险因素最新研究进展[J].现代肿瘤医学,2022,30(4):753-756.
SUN X,QIN W J,LIU L L,et al.Recent advances of research on risk factors of lung cancer[J].J Mod Oncol,2022,30(4):753-756.(in Chinese)
[16] 梁敏,吴宁.女性肺癌的危险因素和筛查现状[J].国际医学放射学杂志,2022,45(5):539-544.
LIANG M,WU N.Risk factors and screening of lung cancer in women[J].Int J Med Radiol,2022,45(5):539-544.(in Chinese)
[17] 何杰,李静,尹昕然,等.1990—2021年中国肺癌发病趋势及未来预测分析[J].实用心脑肺血管病杂志,2025,33(8):1-5.
HE J,LI J,YIN X R,et al.Incidence trend and future prediction of lung cancer in China from 1990 to 2021[J].Pract J Card Cereb Pneumal Vasc Dis,2025,33(8):1-5.(in Chinese)
[18] 倪雪,许宁,王强.基于贝叶斯时空模型探究中国女性肺癌发病风险及其影响因素[J].环境卫生学杂志,2022,12(6):407-414.
NI X,XU N,WANG Q.Analysis on the incidence risk and their influence factors of female lung cancer in China based on Bayesian spatio-temporal model[J].J Environ Hyg,2022,12(6):407-414.(in Chinese)
[1] 李玉荣, 王冬飞, 高媛媛, 蒋园园, 林君英, 肖段段. 2010—2024年萧山区结直肠癌发病趋势分析[J]. 预防医学, 2025, 37(9): 927-931,936.
[2] 李君, 朱婷婷, 胡文雪. 2005—2023年温州市丙型病毒性肝炎流行特征分析[J]. 预防医学, 2025, 37(9): 932-936.
[3] 胡晓强, 刘艳, 周思凡, 张子喆, 王雨达, 沈建勇. 2014—2023年湖州市流行性感冒流行特征分析[J]. 预防医学, 2025, 37(9): 959-962.
[4] 李克, 庞志峰, 吴晓虹, 王诚, 何瑶, 唐慧玲. 2007—2024年金华市钩端螺旋体病流行特征分析[J]. 预防医学, 2025, 37(8): 818-821.
[5] 冷雪, 傅淑琴, 舒纪为, 谭启龙, 李科峰. 舟山市带状疱疹首诊病例特征分析[J]. 预防医学, 2025, 37(7): 701-704.
[6] 胡锦秀, 方婷婷, 张小敏, 张卉. 胸腔镜下肺癌根治术患者呼吸康复干预效果评价[J]. 预防医学, 2025, 37(7): 687-691.
[7] 朱颖, 郑添. 2013—2023年嘉善县居民期望寿命变化[J]. 预防医学, 2025, 37(6): 598-602.
[8] 董沙沙, 项云飞. 2014—2023年余姚市原发性肝癌死亡与疾病负担分析[J]. 预防医学, 2025, 37(6): 603-607.
[9] 丁哲渊, 杨研, 傅天颖, 鲁琴宝, 王心怡, 吴昊澄, 刘魁, 林君芬, 吴晨. 2024年浙江省法定传染病疫情分析[J]. 预防医学, 2025, 37(5): 433-438,442.
[10] 任露露, 顾嘉昌, 闵艺璇, 张思晨, 乔健健, 肖月, 胡静. 2016—2023年宜兴市脑卒中发病趋势分析[J]. 预防医学, 2025, 37(5): 498-502.
[11] 李慧君, 叶振淼, 樊丽辉, 郑宇航, 谢轶敏, 姜雪霞, 高豪俊, 张默涵, 罗永园. 2015—2023年温州市老年人跌倒死亡趋势与减寿分析[J]. 预防医学, 2025, 37(5): 460-464.
[12] 周沁易, 马涛, 赵跃媛, 王恒学, 吴小清, 丁松宁, 苏晶晶. 2004—2022年南京市法定传染病发病趋势分析[J]. 预防医学, 2025, 37(5): 476-480.
[13] 王洪岩, 任飞林, 刘小琦, 金玫华, 吴振乾. 2009—2023年湖州市HIV/AIDS病例新发现率趋势分析[J]. 预防医学, 2025, 37(4): 395-399.
[14] 叶振淼, 樊丽辉, 姜雪霞, 郑宇航, 张默涵, 罗永园, 谢轶敏, 李慧君, 金茜. 2014—2023年温州市胃癌死亡及减寿趋势分析[J]. 预防医学, 2025, 37(3): 267-271.
[15] 王越, 黄晓彤, 赵菲, 丁莉莉, 吴炳义. 中晚期肺癌患者不同治疗方案对生命质量的影响[J]. 预防医学, 2025, 37(3): 272-275.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed